AOTI Share Price Performance
UK£1.39
0.81 (141.74%)
31.8% overvalued intrinsic discount
UK£1.06
Fair Value
Price UK£1.39
AnalystConsensusTarget UK£1.06
AnalystHighTarget UK£1.14
Fair ValueUK£1.06
Share Pricen/a
Narrative Update • Aug 11
AOTI, Inc. Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
AOTI Community Narratives
AN
Fair Value
·Fair Value UK£1.06 31.8% overvalued intrinsic discount
Broader CMS Coverage And Home Care Trends Will Reshape This Chronic Wound Therapy Business
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value UK£1.14 21.9% overvalued intrinsic discount
Medicare Access And Home Care Trends Will Transform This Chronic Wound Therapy Opportunity
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Medicare Access And Home Care Trends Will Transform This Chronic Wound Therapy Opportunity
AOTI treats hard-to-heal wounds with an at-home oxygen therapy, and a key Medicare decision could open the door to far wider access. But the same reimbursement system that could fuel growth could also stall it, with policy shifts and payment delays posing real setbacks.Read more
AN
UK£1.14
21.9% overvalued intrinsic discount
Fair Value
Revenue
19.6% p.a.
Profit Margin
9.27%
Future PE
19.31x
Price in 2029
UK£1.42
Broader CMS Coverage And Home Care Trends Will Reshape This Chronic Wound Therapy Business
AOTI bets that insurance coverage opens the door for many more people with hard-to-heal wounds to get its oxygen-based treatment at home, using a nationwide care network it already runs. The big question is whether that coverage change arrives soon enough—and whether payment delays, rising costs, or competitors slow the momentum.Read more
AN
UK£1.06
31.8% overvalued intrinsic discount
Fair Value
Revenue
15.93% p.a.
Profit Margin
8.1%
Future PE
21.96x
Price in 2029
UK£1.3
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
AOTI: Medicare Coverage Progress Is Expected To Unlock Wider Wound Care Adoption
Fair Value: UK£1.14 21.9% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AOTI: US Coverage Progress And Wound Data Will Guide Measured Re-Rating
Fair Value: UK£1.06 31.8% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
AOTI, Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Sep 30, 2026
- 0.025
- 87.49%
- 4.01%
- 99.6%
About AOTI
- Founded
- 2008
- Employees
- 90
- CEO
- WebsiteView website
AOTI, Inc., together with its subsidiaries, patents, manufacturers, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, a negative pressure disposable wound therapy system for use in home, acute and extended care settings. AOTI, Inc. was incorporated in 2008 and is based in Oceanside, California.
Recent AOTI News & Updates
Narrative Update • Jul 27
